Red Blood Cells in Type 2 Diabetes Impair Cardiac Post-Ischemic Recovery Through an Arginase-Dependent Modulation of Nitric Oxide Synthase and Reactive Oxygen Species.
JACC Basic Transl Sci
; 3(4): 450-463, 2018 Aug.
Article
em En
| MEDLINE
| ID: mdl-30175269
ABSTRACT
This study tested the hypothesis that red blood cell (RBC) arginase represents a potential therapeutic target in ischemia-reperfusion in type 2 diabetes. Post-ischemic cardiac recovery was impaired in hearts from db/db mice compared with wild-type hearts. RBCs from mice and patients with type 2 diabetes attenuated post-ischemic cardiac recovery of nondiabetic hearts. This impaired cardiac recovery was reversed by inhibition of RBCs arginase or nitric oxide synthase. The results suggest that RBCs from type 2 diabetics impair cardiac tolerance to ischemia-reperfusion via a pathway involving arginase activity and nitric oxide synthase-dependent oxidative stress.
ABH, 2 (S)-amino-6-boronohexanoic acid; KH, Krebs-Henseleit; L-NAME, NG-nitro-L-arginine methyl ester; LVDP, left ventricular developed pressure; LVEDP, left ventricular end-diastolic pressure; NAC, N-acetylcysteine; NO, nitric oxide; NOS, nitric oxide synthase; RBC, red blood cell; ROS, reactive oxygen species; WT, wild type; arginase; dP/dt, the first derivative of left ventricular pressure; eNOS, endothelial nitric oxide synthase; iNOS, inducible isoform of nitric oxide synthase; nitric oxide synthase; nor-NOHA, Nω-hydroxy-nor-L-arginine; reactive oxygen species; red blood cells; type 2 diabetes
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article